Back to Search
Start Over
The mechanism of Ara-C-induced apoptosis of differentiating cerebellar granule neurons.
- Source :
-
The European journal of neuroscience [Eur J Neurosci] 1999 Mar; Vol. 11 (3), pp. 1073-84. - Publication Year :
- 1999
-
Abstract
- Neurotoxicity is one of the side-effects of the therapeutically useful antitumour agent, Ara-C (or 1-beta-d-arabinofuranosyl-cytosine, cytarabine). This agent is also reported to induce cell death of cultured neurons. In this study, we show that Ara-C-induced death of differentiating rat cerebellar granule neurons is prevented by cycloheximide at concentrations corresponding to its action in preventing protein synthesis. The death is accompanied by cleavage of the caspase substrate poly ADP ribose polymerase (PARP) and c-Abl-dependent activation of the stress-activated protein kinases c-Jun N-terminal kinase and p38. However, c-Jun levels do not rise and the activation of the stress-activated protein kinases is not required for this form of neuronal death. Cyclin-dependent kinase (cdk) activity and inappropriate cell-cycle re-entry have been implicated in some forms of death in differentiated neurons. Here we show that Ara-C-induced death of cerebellar granule neurons is prevented by an inhibitor of cdk4, whereas inhibition of cdk1, -2 and -5 mimics the death, and non-cdk4/6 cdks are inhibited by Ara-C treatment. Cdk1 and -2 are dramatically down-regulated during neuronal differentiation, and neither Ara-C nor inhibition of these cdks induces death in mature neurons. This mechanism could also play a significant role in the neurotoxicity associated with the therapeutic use of Ara-C, as cdk levels can be upregulated in stressed neurons of adult brain. We propose that the balance between cdk4/6 and cdk1/2/5 activity may determine the survival of early differentiating neurons, and that DNA-damaging agents may induce neuronal death by inhibiting cdk1/2/5 under conditions which require these activities for survival.
- Subjects :
- Androstadienes pharmacology
Animals
Apoptosis drug effects
Benzamides
CDC2 Protein Kinase analysis
CDC2 Protein Kinase metabolism
Cell Differentiation physiology
Cell Survival physiology
Cerebellum cytology
Cyclin-Dependent Kinase 2
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 5
Cyclin-Dependent Kinases analysis
Cyclin-Dependent Kinases metabolism
Enzyme Inhibitors pharmacology
Flavonoids pharmacology
Imatinib Mesylate
Imidazoles pharmacology
Mitogen-Activated Protein Kinase 12
Neurons chemistry
Neurons enzymology
Piperazines pharmacology
Piperidines pharmacology
Poly (ADP-Ribose) Polymerase-1
Poly(ADP-ribose) Polymerases
Protein Kinases metabolism
Protein Serine-Threonine Kinases analysis
Protein Serine-Threonine Kinases metabolism
Proteins metabolism
Purines pharmacology
Pyridines pharmacology
Pyrimidines pharmacology
Rats
Roscovitine
Signal Transduction physiology
Stress, Physiological enzymology
Wortmannin
Antimetabolites, Antineoplastic pharmacology
Apoptosis physiology
CDC2-CDC28 Kinases
Cytarabine pharmacology
Mitogen-Activated Protein Kinases
Neurons cytology
Proto-Oncogene Proteins
Subjects
Details
- Language :
- English
- ISSN :
- 0953-816X
- Volume :
- 11
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The European journal of neuroscience
- Publication Type :
- Academic Journal
- Accession number :
- 10103100
- Full Text :
- https://doi.org/10.1046/j.1460-9568.1999.00520.x